Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor J Gallagher

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Toxins|October 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing InformationKhashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Toxins|April 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442"Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Aesthetic Surgery Journal|September 22, 2018
Aesthetic Treatment Positively Impacts Social Perception: Analysis of Subjects From the HARMONY StudySteven Dayan, Alexander Rivkin, Jonathan M Sykes, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 14, 2019
Maximizing Panfacial Aesthetic Outcomes: Findings and Recommendations From the HARMONY StudyMichael S Kaminer, Joel L Cohen, Ava Shamban, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 18, 2014
A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosisSteven G Yoelin, Steven Fagien, Sue Ellen Cox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 11, 2020
A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 StudyJeremy B Green, Kavita Mariwalla, Kyle Coleman, et al.
The Journal of Clinical and Aesthetic Dermatology|September 19, 2019
Impact of Smoking and Alcohol Use on Facial Aging in Women: Results of a Large Multinational, Multiracial, Cross-sectional SurveyGreg D Goodman, Joely Kaufman, Doris Day, et al.
Experimental Neurology|May 9, 2006
Analysis of the neurogenic potential of multipotent skin-derived precursorsKarl J L Fernandes, Nao R Kobayashi, Conor J Gallagher, et al.
Toxins|March 26, 2025
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinAAaron Ellenbogen, Robert A Hauser, Atul T Patel, et al.
Plastic and Reconstructive Surgery|October 15, 2019
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)Jean D Carruthers, Steve Fagien, John H Joseph, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Toxins|October 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing InformationKhashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Toxins|April 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442"Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Aesthetic Surgery Journal|September 22, 2018
Aesthetic Treatment Positively Impacts Social Perception: Analysis of Subjects From the HARMONY StudySteven Dayan, Alexander Rivkin, Jonathan M Sykes, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 14, 2019
Maximizing Panfacial Aesthetic Outcomes: Findings and Recommendations From the HARMONY StudyMichael S Kaminer, Joel L Cohen, Ava Shamban, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 18, 2014
A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosisSteven G Yoelin, Steven Fagien, Sue Ellen Cox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 11, 2020
A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 StudyJeremy B Green, Kavita Mariwalla, Kyle Coleman, et al.
The Journal of Clinical and Aesthetic Dermatology|September 19, 2019
Impact of Smoking and Alcohol Use on Facial Aging in Women: Results of a Large Multinational, Multiracial, Cross-sectional SurveyGreg D Goodman, Joely Kaufman, Doris Day, et al.
Experimental Neurology|May 9, 2006
Analysis of the neurogenic potential of multipotent skin-derived precursorsKarl J L Fernandes, Nao R Kobayashi, Conor J Gallagher, et al.
Toxins|March 26, 2025
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinAAaron Ellenbogen, Robert A Hauser, Atul T Patel, et al.
Plastic and Reconstructive Surgery|October 15, 2019
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)Jean D Carruthers, Steve Fagien, John H Joseph, et al.
Pageof 7